搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Elusimicrobium minutum UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP458480EKE
CSB-EP458480EKE
CSB-BP458480EKE
CSB-MP458480EKE
CSB-EP458480EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elusimicrobium minutum N utilization substance protein B homolog (nusB) CSB-YP458481EKE
CSB-EP458481EKE
CSB-BP458481EKE
CSB-MP458481EKE
CSB-EP458481EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elusimicrobium minutum Non-canonical purine NTP pyrophosphatase (Emin_1305) CSB-YP458482EKE
CSB-EP458482EKE
CSB-BP458482EKE
CSB-MP458482EKE
CSB-EP458482EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elusimicrobium minutum 50S ribosomal protein L36 (rpmJ) CSB-YP458483EKE
CSB-EP458483EKE
CSB-BP458483EKE
CSB-MP458483EKE
CSB-EP458483EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elusimicrobium minutum 50S ribosomal protein L22 (rplV) CSB-YP458484EKE
CSB-EP458484EKE
CSB-BP458484EKE
CSB-MP458484EKE
CSB-EP458484EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elusimicrobium minutum 50S ribosomal protein L7/L12 (rplL) CSB-YP458485EKE
CSB-EP458485EKE
CSB-BP458485EKE
CSB-MP458485EKE
CSB-EP458485EKE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Loxosceles intermedia Sphingomyelin phosphodiesterase D LiSicTox-alphaIA2bii CSB-YP458486LRA
CSB-EP458486LRA
CSB-BP458486LRA
CSB-MP458486LRA
CSB-EP458486LRA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica ATP synthase subunit a, chloroplastic (atpI), partial CSB-YP458487GHI1
CSB-EP458487GHI1
CSB-BP458487GHI1
CSB-MP458487GHI1
CSB-EP458487GHI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica 30S ribosomal protein S14, chloroplastic (rps14) CSB-YP458488GHI
CSB-EP458488GHI
CSB-BP458488GHI
CSB-MP458488GHI
CSB-EP458488GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica Chloroplast envelope membrane protein (cemA), partial CSB-YP458489GHI1
CSB-EP458489GHI1
CSB-BP458489GHI1
CSB-MP458489GHI1
CSB-EP458489GHI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP458490GHI
CSB-EP458490GHI
CSB-BP458490GHI
CSB-MP458490GHI
CSB-EP458490GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica NAD (P)H-quinone oxidoreductase subunit H, chloroplastic CSB-YP458491GHI
CSB-EP458491GHI
CSB-BP458491GHI
CSB-MP458491GHI
CSB-EP458491GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Guizotia abyssinica Cytochrome c biogenesis protein ccsA (ccsA), partial CSB-YP458492GHI
CSB-EP458492GHI
CSB-BP458492GHI
CSB-MP458492GHI
CSB-EP458492GHI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dextransucrase 1 (dsrF) CSB-YP458493LPG
CSB-EP458493LPG
CSB-BP458493LPG
CSB-MP458493LPG
CSB-EP458493LPG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Chromosomal replication initiator protein DnaA (dnaA) CSB-YP458494EXZ
CSB-EP458494EXZ
CSB-BP458494EXZ
CSB-MP458494EXZ
CSB-EP458494EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Phosphomethylpyrimidine synthase (thiC), partial CSB-YP458495EXZ
CSB-EP458495EXZ
CSB-BP458495EXZ
CSB-MP458495EXZ
CSB-EP458495EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis 50S ribosomal protein L25 (rplY) CSB-YP458496EXZ
CSB-EP458496EXZ
CSB-BP458496EXZ
CSB-MP458496EXZ
CSB-EP458496EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Arginine--tRNA ligase (argS), partial CSB-YP458497EXZ
CSB-EP458497EXZ
CSB-BP458497EXZ
CSB-MP458497EXZ
CSB-EP458497EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Glutamate--tRNA ligase (gltX), partial CSB-YP458498EXZ
CSB-EP458498EXZ
CSB-BP458498EXZ
CSB-MP458498EXZ
CSB-EP458498EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Porphyromonas gingivalis Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP458499EXZ
CSB-EP458499EXZ
CSB-BP458499EXZ
CSB-MP458499EXZ
CSB-EP458499EXZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>